Sanofi admits next big discovery may come from outside its labs in announcing bioscience link

French pharma major Sanofi (Euronext: SAN) announced the creation of a partnering office with UK-based Stevenage Bioscience Catalyst (SBC) on Wednesday.

The collaboration is aimed at helping Sanofi to engage with the UK’s thriving network of bioscience companies and academia.

Yvonne Naughton, Sanofi’s head of external science and partnering for the UK and Ireland, said: “Sanofi is committed to bringing breakthrough science to the clinic and to accelerate the translation of innovation into effective treatments for patients. At Sanofi we recognize that the next big discovery may come from outside of our own laboratories. Core to our strategy is to build strong relationships with biotechnology organisations, research institutes and academic centers.”